SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

SOCIETY FOR BRAIN MAPPING AND THERAPEUTICS

BREAKING BOUNDARIES OF SCIENCE, TECHNOLOGY, MEDICINE, ART & HEALTHCARE POLICY

Psychedelics

The Psychedelics SBMT Subcommittee, focuses on research on the use of psychedelics for diverse neuropsychiatric illnesses.

Conor H Murray

Psychedelics Subcommittee | Neuropsychiatric Subcommittee
Conor H. Murray, PhD is a neuroscientist who has recently completed a postdoctoral fellowship (NIDA T32) at the University of Chicago. Trained on the neurobiology of substance use disorders, his prior work has spanned both preclinical and translational studies, from projects investigating the breakdown of endocannabinoid signaling during cocaine withdrawal to the acute cognitive effects of THC in adolescent men and women, and potential roles for LSD and MDMA in the treatment of anxiety, depression, and autism spectrum disorders

Sara Lhassani

MD | Research Fellow (2023-2024)
Second-year resident in neurology in Morocco

Nima Manavi

Medical Student | SBMT/WBMF Intern (2021-2023)

Oreoluwa Kolade-Ernest

MD | Research Fellow (2022)

Keerthy Sunder

WBMF Golden Axon Leadership Award, 2023
CEO, Karma Doctors & Karma TMS, Inc Founder, The Sunder Foundation, Assistant Clinical Professor, University of California Riverside, CA, USA

David Baron

DO, MSEd | Neuropsychiatry and Innovation Subcommittee
Senior Vice President and Provost of the Western University of Health Sciences and serves as Chief Academic Officer of the university. He is responsible for academic, accreditation, and budgetary affairs.
1 / 1